1. Home
  2. KE vs PBYI Comparison

KE vs PBYI Comparison

Compare KE & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$26.17

Market Cap

564.2M

Sector

Technology

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$9.12

Market Cap

467.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
PBYI
Founded
1961
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
564.2M
467.2M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
KE
PBYI
Price
$26.17
$9.12
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
206.6K
270.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
66.18
N/A
EPS
1.13
0.08
Revenue
$1,431,378,000.00
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$22.16
$113.13
Revenue Growth
N/A
N/A
52 Week Low
$21.60
$4.30
52 Week High
$33.19
$9.74

Technical Indicators

Market Signals
Indicator
KE
PBYI
Relative Strength Index (RSI) 53.09 54.10
Support Level $23.42 $8.78
Resistance Level $26.85 $9.55
Average True Range (ATR) 0.70 0.37
MACD 0.17 -0.05
Stochastic Oscillator 83.15 45.53

Price Performance

Historical Comparison
KE
PBYI

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: